Optimal duration of additional therapy after favorable response to lamivudine in patients with HBeAg-negative chronic hepatitis B: a randomised trial

被引：0
|
作者：
Enomoto, Masaru [1 ]
Tamori, Akihiro [1 ]
Toyama, Madoka [1 ]
Hayashi, Kohmoto Takehiro [1 ]
Morikawa, Hiroyasu [1 ]
Jomura, Hisato [1 ]
Habu, Daiki [1 ]
Sakaguchi, Hiroki [1 ]
Takeda, Tadashi [1 ]
Shiomi, Susumu [2 ]
Nishiguchi, Shuhei [3 ]
Kawada, Norifumi [1 ]
机构：
[1] Osaka City Univ, Sch Med, Dept Hepatol, Osaka, Japan
[2] Osaka City Univ, Sch Med, Dept Nucl Med, Osaka, Japan
[3] Hyogo Med Univ, Dept Internal Med, Osaka, Japan
来源：
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY | 2007年 / 22卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：A250 / A250
页数：1
相关论文
共 50 条
  • [41] Treatment paradigms in hepatitis B e antigen negative (HBeAg-negative) chronic hepatitis B patients
    Hadziyannis, S. J.
    JOURNAL OF CLINICAL VIROLOGY, 2006, 36 : S15 - S15
  • [42] Combination treatment in HBeAg-negative chronic hepatitis B
    Tziomalos, Konstantinos
    WORLD JOURNAL OF HEPATOLOGY, 2009, 1 (01) : 43 - 47
  • [43] Short-term entecavir versus lamivudine therapy for HBeAg-negative patients with acute-on-chronic hepatitis B liver failure
    Lai, Jing
    Yan, Ying
    Mai, Li
    Zheng, Yu-Bao
    Gan, Wei-Qiang
    Ke, Wei-Min
    HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL, 2013, 12 (02) : 154 - 159
  • [44] Long-term adefovir plus lamivudine therapy does not decrease creatinine clearance in HBeAg-negative chronic hepatitis B patients
    Manolakopoulos, Spilios
    Striki, Athanasia
    Deutsch, Melanie
    Mela, Maria
    Ketikoglou, Ioannis
    Tzourmakliotis, Dimitrios
    Manesis, Emanuel K.
    Papatheodoridis, George V.
    LIVER INTERNATIONAL, 2011, 31 (10) : 1525 - 1532
  • [45] Predictors of HBsAg Seroclearance in HBeAg-Negative Chronic Hepatitis B Patients
    Kwak, Min-Sun
    Cho, Eun Ju
    Jang, Eun Sun
    Lee, Jeong-Hoon
    Yu, Su Jong
    Kim, Yoon Jun
    Yoon, Jung-Hwan
    Lee, Hyo-Suk
    DIGESTION, 2011, 84 : 23 - 28
  • [46] Natural history of HBeAG-negative chronic hepatitis B
    Ghany M.G.
    Liang T.J.
    Current Hepatitis Reports, 2006, 5 (1) : 27 - 32
  • [47] Clinical and virological response to adefovir dipovixil for lamivudine-resistant HBeAg-negative hepatitis B
    Scotto, G
    Palumbo, E
    Fazio, V
    Tartaglia, A
    Saracino, A
    Angarano, G
    NEW MICROBIOLOGICA, 2005, 28 (03): : 193 - 197
  • [48] Adding-on versus switching-to adefovir therapy in lamivudine-resistant HBeAg-negative chronic hepatitis B
    Rapti, Irene
    Dimon, Evangelini
    Mitsoula, Panayota
    Hadziyannis, Stephanos J.
    HEPATOLOGY, 2007, 45 (02) : 307 - 313
  • [49] Combination of adefovir dipivoxil with lamivudine vs. adefovir alone in lamivudine-resistant HBeAg-negative chronic hepatitis B patients
    Rapti, Irene N.
    Dimou, Evangelini
    Mitsoula, Panayota
    Hadziyannis, Stephanos J.
    HEPATOLOGY, 2006, 44 (04) : 558A - 559A
  • [50] Sustained response to peginterferon alfa-2a (40 kD) with or without lamivudine in Asian patients with HBeAg-positive and HBeAg-negative chronic hepatitis B
    Piratvisuth, Teerha
    Lau, George
    Chao, You-Chen
    Jin, Rui
    Chutaputti, Anuchit
    Zhang, Q. -B.
    Tanwandee, Tawesak
    Button, Peter
    Popescu, Matei
    HEPATOLOGY INTERNATIONAL, 2008, 2 (01) : 102 - 110
12345